Publications by authors named "Rina Chin"

Claim this Profile
A
Association Between Early Weight Loss and Metabolic Outcomes with Tirzepatide in Japanese Patients with Type 2 Diabetes: A SURPASS J Post Hoc Analysis.
Hanaka Mimura, Tomonori Oura, Rina Chin, Tetsuaki Hirase, Dai Shimono

Diabetes Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of bodyweight loss with changes in lipids, blood pressure, and fasting serum glucose following tirzepatide treatment in Japanese participants with type 2 diabetes: A post hoc analysis of the SURPASS J-mono trial.
Hanaka Mimura, Tomonori Oura, Rina Chin, Masakazu Takeuchi, Kazuya Fujihara

J Diabetes Investig· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of Severe Hypoglycemia Risk Among Patients with Diabetes Treated with Ultra-Rapid Lispro in Japan.
Seiko Mizuno, Machiko Minatoya, Satoshi Osaga, Rina Chin, Makoto Imori

Adv Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation study of case-identifying algorithms for severe hypoglycemia using hospital administrative data in Japan.
Satoshi Osaga, Takeshi Kimura, Yasuyuki Okumura, Rina Chin, Makoto Imori

PLoS One· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and effectiveness of dulaglutide 0.75 mg in Japanese patients with type 2 diabetes in real-world clinical practice: 36 month post-marketing observational study.
Rina Chin, Soshi Nagaoka, Haru Nakasawa, Yoko Tanaka, Nobuya Inagaki

J Diabetes Investig· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of tirzepatide as an add-on to single oral antihyperglycaemic medication in patients with type 2 diabetes in Japan (SURPASS J-combo): a multicentre, randomised, open-label, parallel-group, phase 3 trial.
Takashi Kadowaki, Rina Chin, Akichika Ozeki, Takeshi Imaoka, Yoshihiro Ogawa

Lancet Diabetes Endocrinol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization of glucagon-like peptide-1 receptor agonists and changes in clinical characteristics in patients with type 2 diabetes by chronic kidney disease stage in Japan: A descriptive observational study using a nationwide electronic medical records database.
Naoki Hirose, Naoto Tsujimoto, Taeko Katayose, Rina Chin

Diabetes Obes Metab· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and effectiveness of empagliflozin in Japanese patients with type 2 diabetes: interim analysis from a post-marketing surveillance study.
Kohei Kaku, Rina Chin, Yusuke Naito, Hristo Iliev, Rie Ikeda

Expert Opin Drug Saf· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness Analysis of Empagliflozin in Japan Based on Results From the Asian subpopulation in the EMPA-REG OUTCOME Trial.
Kohei Kaku, Masakazu Haneda, Hiroyuki Sakamaki, Atsutaka Yasui, Tatsunori Murata, Rina Chin

Clin Ther· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Ezetimibe on LDL-C Lowering and Atherogenic Lipoprotein Profiles in Type 2 Diabetic Patients Poorly Controlled by Statins.
Kentaro Sakamoto, Mitsunobu Kawamura, Takahide Kohro, Masao Omura, Takayuki Watanabe, Rina Chin

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case of Rathke's Cleft Cyst Associated with Transient Central Adrenal Insufficiency and Masked Diabetes Insipidus.
Masahiro Asakawa, Rina Chin, Yoshihiro Niitsu, Tetsuo Sekine, Arisa Niwa

Case Rep Endocrinol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Criteria of obesity and obesity disease in Japan].
Rina Chin, Shigeru Miyazaki

Nihon Rinsho· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating levels of ganglioside GM3 in metabolic syndrome: A pilot study.
Takashige Sato, Yutaka Nihei, Masakazu Nagafuku, Seiichi Tagami, Rina Chin

Obes Res Clin Pract· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis